The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Technology-enhanced acceleration of germline evaluation for therapy (TARGET): Results of a randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing.
 
Veda N. Giri
Stock and Other Ownership Interests - Novopyxis (I)
Honoraria - Ambry Genetics
 
Scott W. Keith
No Relationships to Disclose
 
Heather H. Cheng
Consulting or Advisory Role - AstraZeneca; AstraZeneca (I)
Research Funding - Clovis Oncology (Inst); Color Genomics Foundation (Inst); Janssen (Inst); Medivation/Astellas (Inst); Phosplatin Therapeutics (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
Other Relationship - Janssen
 
Amy Leader
Honoraria - Pfizer
Research Funding - Merck; Pfizer
Travel, Accommodations, Expenses - Pfizer; Pfizer
 
Laura Gross
No Relationships to Disclose
 
Tatiana Sanchez Nolasco
No Relationships to Disclose
 
Nataliya Byrne
No Relationships to Disclose
 
Rebecca Hartman
No Relationships to Disclose
 
Lauren Brown
No Relationships to Disclose
 
Christopher Michael Pieczonka
Employment - Associated Medical Professionals of New York
Leadership - Associated Medical Professionals of New York
Stock and Other Ownership Interests - US Urology Partners
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Janssen; Merck; Myovant Sciences; Pfizer/Astellas; Sun Pharma
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Janssen Oncology; Merck; Pfizer/Astellas; Sun Pharma; Sun Pharma; Tolmar
Speakers' Bureau - Astellas Pharma; Bayer; Dendreon; Foundation Medicine; Janssen Oncology; Myovant Sciences; Pfizer; Sun Pharma
Research Funding - Advantagene; Astellas Pharma; AstraZeneca; Bayer; Dendreon; Janssen Oncology; Merck; Pfizer
 
Leonard G. Gomella
Consulting or Advisory Role - AstraZeneca/Merck; Janssen Oncology; Lantheus Medical Imaging
Patents, Royalties, Other Intellectual Property - Patents Held by Thomas Jefferson University
 
William Kevin Kelly
Honoraria - Janssen Oncology
Research Funding - Amgen (Inst); Bayer (Inst); BioClin Therapeutics (Inst); Endocyte (Inst); Exelixis (Inst); Janssen Oncology (Inst); Novartis (Inst); Roche (Inst); Sarah Cannon Research Institute (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Janssen Oncology
 
Costas D. Lallas
No Relationships to Disclose
 
Nathan Handley
Research Funding - Nektar (Inst)
 
Patrick Johnston Mille
No Relationships to Disclose
 
James Ryan Mark
No Relationships to Disclose
 
Gordon Andrew Brown
Honoraria - Astellas Pharma; Bayer; Janssen Oncology; Merck; Pfizer
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen Oncology; Merck; Pfizer
Speakers' Bureau - Astellas Pharma; Bayer; Janssen Oncology; Merck; Pfizer
Research Funding - Bayer; Janssen Oncology
Travel, Accommodations, Expenses - Bayer; Janssen Oncology; Pfizer
 
Sameer Chopra
No Relationships to Disclose
 
Alexandra McClellan
No Relationships to Disclose
 
Stacy Loeb
Stock and Other Ownership Interests - Gilead Sciences (I)